€
1.15
Nov 29
New Key Statistics Module, Z-Score and F-Score
FRA:3FDA Key Ratios
Market Cap € M | 101.95 |
Enterprise Value € M | 286.41 |
P/E(ttm) | 14.38 |
PE Ratio without NRI | 14.38 |
Forward PE Ratio | 11.76 |
Price/Book | 0.64 |
Price/Sales | 5.54 |
Price/Free Cash Flow | 19.80 |
Price/Owner Earnings | 30.97 |
Payout Ratio % | -- |
Revenue (TTM) € M | 18.00 |
EPS (TTM) € | 0.08 |
Beneish M-Score | 2.59 |
10-y EBITDA Growth Rate % | -- |
5-y EBITDA Growth Rate % | -- |
y-y EBITDA Growth Rate % | -55.60 |
EV-to-EBIT | 17.62 |
EV-to-EBITDA | 16.25 |
PEG | -- |
Shares Outstanding M | 86.39 |
Net Margin (%) | 38.14 |
Operating Margin % | 54.23 |
Pre-tax Margin (%) | 45.75 |
Quick Ratio | 4.02 |
Current Ratio | 4.02 |
ROA % (ttm) | 2.04 |
ROE % (ttm) | 4.83 |
ROIC % (ttm) | 2.68 |
Dividend Yield % | 2.65 |
Altman Z-Score | 0.70 |
FRA:3FDA Number of Guru Trades
FRA:3FDA Volume of Guru Trades
Gurus Latest Trades with FRA:3FDA
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
FRA:3FDA is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data